Benefit from our ultra sensitive pharmacokinetic (PK) and toxicokinetic (TK) bioanalytical sample testing support
Chimera Biotec offers PK assessment for modern biologics, supporting projects throughout all phases of drug development. Combining a broad assay quantitative range with superior sensitivities, we conduct biologics PK analysis using one assay format only. From high dosing in TOX via extreme low dosing in dose-escalation to later stages, we provide regulated PK sample testing using validated methods which are based on the same assay.
This eliminates the need to run several assays to pair sensitivity and range.